Facet Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.14M Buy
11,987
+803
+7% +$206K 0.04% 75
2026
Q2
$2.81M Sell
11,184
-231
-2% -$49.7K 0.04% 76
2026
Q1
$2.48M Buy
11,415
+6,376
+127% +$1.41M 0.04% 72
2025
Q4
$1.1M Buy
5,039
+1,256
+33% +$286K 0.02% 96
2025
Q3
$876K Buy
3,783
+216
+6% +$44K 0.02% 90
2025
Q2
$674K Buy
3,567
+1,086
+44% +$202K 0.02% 87
2025
Q1
$486K Buy
2,481
+83
+3% +$16.1K 0.01% 87
2024
Q4
$457K Sell
2,398
-41
-2% -$7.54K 0.01% 92
2024
Q3
$496K Buy
2,439
+742
+44% +$138K 0.01% 90
2024
Q2
$317K Sell
1,697
-76
-4% -$12.6K 0.01% 102
2024
Q1
$289K Buy
1,773
+326
+23% +$56.2K 0.01% 94
2023
Q4
$251K Buy
+1,447
New +$211K 0.01% 97
2023
Q3
– Sell
-1,754
Closed -$262K – 96
2023
Q2
$262K Buy
1,754
+104
+6% +$15.3K 0.01% 80
2023
Q1
$263K Sell
1,650
-13
-0.8% -$1.99K 0.02% 64
2022
Q4
$253K Buy
1,663
+30
+2% +$4.6K 0.02% 61
2022
Q3
$242K Buy
+1,633
New +$234K 0.02% 59

Other funds holding ABBV

Facet Wealth's ABBV Position: Q3 2026 in Review

Facet Wealth increased its AbbVie (ABBV) stake by 7.2% in Q3 2026, buying an estimated $206K and bringing the position to 11,987 shares worth $3.14M. The position accounts for 0.04% of the portfolio, ranked #75.

Facet Wealth first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Facet Wealth held 11,987 shares of AbbVie worth $3.14M as of Q3 2026.
  • Facet Wealth bought 803 AbbVie shares in Q3 2026, an estimated $206K.
  • AbbVie made up 0.04% of Facet Wealth's portfolio in Q3 2026, its #75 holding.
  • Facet Wealth first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Facet Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.